Semax is built from a fragment of ACTH, a hormone the pituitary gland produces that is involved in stress response signaling. The fragment Semax is based on does not appear to carry the hormonal activity of full-length ACTH, but researchers found it has distinct effects on neurotrophic factor expression. Its main area of study involves BDNF (brain-derived neurotrophic factor), a protein that helps nerve cells grow, mature, and maintain their connections.
In neuronal cell cultures, researchers have measured Semax's effects on BDNF mRNA levels, which is a way to track whether cells are ramping up production of this neurotrophic protein. Animal studies have gone further, looking at markers of synaptic plasticity, which is the ability of connections between neurons to strengthen or weaken over time. Research has also explored how Semax interacts with monoamine systems, specifically the dopamine and serotonin pathways, in brain tissue preparations.
Additional research areas include oxidative stress and antioxidant enzyme activity in neuronal models. Animal behavioral studies have examined associations with learning and memory performance in standard rodent test paradigms. With over 200 published papers, Semax is one of the more established research peptides in the neurotrophic signaling field. For Research Use Only. Not intended for human or veterinary use.